Screener
Tandem Diabetes Care TNDM Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
FAQ
- What is Tandem Diabetes Care's total cost of revenue?
- Tandem Diabetes Care (TNDM) reported total cost of revenue of $109.78M in Q2 2026.
- How has Tandem Diabetes Care's total cost of revenue changed year-over-year?
- Tandem Diabetes Care's total cost of revenue decreased by 4.4% year-over-year, from $114.82M to $109.78M.
- What is the long-term trend for Tandem Diabetes Care's total cost of revenue?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's total cost of revenue has grown at a 9.5% compound annual growth rate (CAGR), from $326.58M to $468.72M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Tandem Diabetes Care's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude